Tofisopam

托非索泮

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTofisopam
Drug Alias NameTofizopam托非索洋GrandaxinEGYT-341
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAnxietyIrritable Bowel Syndrome
Global Approved IndicationsAnxiety
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1974/01/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmos Corp
Active IndicationsAnxiety
Inactive IndicationsIrritable Bowel Syndrome

Other Information

ATC CodeN05BA23
Related LinksWikipediaDrugBankKEGG